Skip to main content

URMC Logo

URMC / Research / Research@URMC
Is It Time for New Strategies to Treat Aggressive Prostate Cancer?

Is It Time for New Strategies to Treat Aggressive Prostate Cancer?

A new URMC study confirms that androgen deprivation therapy, which initially shrinks aggressive prostate tumors, is a double-edged sword that ultimately might fuel the spread of cancer.

4/27/2016
CTSI Incubator Fosters Collaboration on Treatment Targets, Biomarkers for Psoriatic Arthritis

CTSI Incubator Fosters Collaboration on Treatment Targets, Biomarkers for Psoriatic Arthritis

URMC researchers will explore a promisting new biomarker - and possible drug target - for psoriatic arthritis under a $2.5 million grant from the National Institutes of Health. The researchers credit previous funding from a CTSI Incubator award for their success in obtaining this grant. 

4/18/2016
Study Calls Out Need for Blood Transfusion Guidelines

Study Calls Out Need for Blood Transfusion Guidelines

URMC research about the wide variation among physicians and hospitals for blood transfusions during colorectal surgery has triggered a “call to action” for protocols to clear up this long-debated area of medicine.

4/14/2016
Long QT Syndrome Research Honored at Major Heart Meeting

Long QT Syndrome Research Honored at Major Heart Meeting

Long QT syndrome type 3 (LQT3) is a rare heart rhythm disorder that causes young people to die suddenly. New research on the disorder will help physicians specifically tailor treatment for each patient and was recognized at the American College of Cardiology’s annual meeting. 

4/7/2016
Authors Talk “Truth” in Tissue Samples

Authors Talk “Truth” in Tissue Samples

It’s incredible to think that years of scientific research might’ve been conducted with tissue samples that were nearly worthless—but that frustrating reality is what keeps David Hicks, M.D., and other progressive pathologists pushing for improvements.

3/23/2016